Skip to main content
OpenTrials

Clinical trial condition

Gliosarcoma

Explore clinical trials studying Gliosarcoma. Study availability and eligibility vary by location and protocol.

373 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Gliosarcoma trial results

Active, Not Recruiting

Testing the Addition of the Chemotherapy Drug Lomustine (Gleostine) to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Methylated Glioblastoma

NCT05095376

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Highlands Oncology Group - Rogers Rogers, Arkansas, United States
View all 420 locations
View Trial Details
Active, Not Recruiting

Vorinostat and Temozolomide in Treating Patients With Malignant Gliomas

NCT00268385

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +23 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

SurVaxM Vaccine Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

NCT02455557

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Harvard Cancer Center Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details
Active, Not Recruiting

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

NCT03478462

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +62 more
Locations
  • Lucile Packard Children's Hospital Palo Alto, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Duke University Chapel Hill, North Carolina, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details

Related conditions